1. The health and economic burden of bloodstream infections caused by antimicrobial-susceptible and non-susceptible Enterobacteriaceae and Staphylococcus aureus in European hospitals, 2010 and 2011: a multicentre retrospective cohort study;AJ Stewardson;Euro surveillance: bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin,2016
2. In vitro susceptibility to 19 agents other than beta-lactams among third-generation cephalosporin-resistant Enterobacteriaceae recovered on hospital admission;A Mischnik;The Journal of antimicrobial chemotherapy,2017
3. Contact precautions for preventing nosocomial transmission of ESBL-producing Escherichia coli—a point/counterpoint review;S Tschudin-Sutter;Clinical infectious diseases: an official publication of the Infectious Diseases Society of America,2017
4. Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes;E Lautenbach;Clinical infectious diseases: an official publication of the Infectious Diseases Society of America,2001
5. Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern;JD Pitout;The Lancet Infectious diseases,2008